Medicare takes decisive action on new tech stent reimbursement
This article was originally published in Clinica
Executive Summary
In an unprecedented move, Medicare officials have decided to pay 17% more for drug-eluting stents than current stents and, just as remarkably, chose to announce their intention long before the products are even FDA-approved.